Korean J Med Mycol.  2016 Dec;21(4):105-110. 10.17966/KJMM.2016.21.4.105.

Systemic Antifungal Drugs for Onychomycosis

Affiliations
  • 1Department of Dermatology, College of Medicine, Inje University, Korea. pituitarygland@hanmail.net
  • 2Jin Dermatology Clinic, Busan, Korea.

Abstract

Onychomycosis is a common disease that requires appropriate management. Systemic antifungal agents are current standard for onychomycosis treatment. Considering high recurrence rate, selection of the systemic antifungal agent should be based primarily on the causative organism, the potential adverse effects and the risk of drug interactions. Herein, we reviewed systemic antifungal agent for onychomycosis.

Keyword

Fluconazole; Itraconazole; Onychomycosis; Terbinafine

MeSH Terms

Antifungal Agents
Drug Interactions
Fluconazole
Itraconazole
Onychomycosis*
Recurrence
Antifungal Agents
Fluconazole
Itraconazole
Full Text Links
  • KJMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr